跳至主導覽
跳至搜尋
跳過主要內容
國立成功大學 首頁
English
中文
首頁
概要
研究單位
研究成果
專案
學生論文
設備
獎項
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
吳 泓璁
副教授
內科學科
電話
886 6 2353535 ext 5382
電子郵件
microbe0905702
yahoo.com
tw
h-index
2051
引文
23
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2007
2025
每年研究成果
概覽
指紋
網路
專案
(1)
研究成果
(85)
類似的個人檔案
(6)
指紋
查看啟用 Hung-Tsung Wu 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Pharmacology, Toxicology and Pharmaceutical Science
Insulin Resistance
100%
Diabetes Mellitus
80%
Fatty Liver
74%
Peroxisome Proliferator Activated Receptor
59%
Nonalcoholic Fatty Liver
57%
Fetuin A
56%
Liver Cell Carcinoma
56%
Receptor
55%
Cardiotrophin 1
53%
Imidazoline
53%
Impaired Glucose Tolerance
43%
G Protein Coupled Receptor 40
40%
Non Insulin Dependent Diabetes Mellitus
38%
Evodiamine
35%
Rilmenidine
35%
STAT3 Protein
35%
Cotton Pellet-Induced Granuloma
35%
Oleic Acid
34%
Endorphin
32%
Biological Marker
29%
Streptozotocin
26%
Immune Checkpoint Inhibitor
24%
Fenretinide
19%
Alanine Aminotransferase
18%
Alcohol Intoxication
17%
Hypophysis Adenylate Cyclase Activating Polypeptide
17%
Nonnutritive Sweetener
17%
Acesulfame Potassium
17%
Fibrinogen
17%
Programmed Death 1 Receptor
17%
Stevioside
17%
Fungal Extract
17%
Fomitopsis
17%
Stomatitis
17%
Nivolumab
17%
Phospholipid Hydroperoxide Glutathione Peroxidase
17%
Pembrolizumab
17%
Agmatine
17%
Reactive Oxygen Metabolite
17%
Pancreas Cancer
17%
Bladder Cancer
17%
Ghrelin
17%
Antioxidant
17%
Unsaturated Fatty Acid
17%
Allantoin
17%
Metformin
17%
Lenvatinib
17%
Propylene Glycol
17%
Glucagon Like Peptide 1 Receptor Agonist
17%
Alternative Complement Pathway C3 C5 Convertase
17%
Biochemistry, Genetics and Molecular Biology
Synapsin I
73%
Impaired Glucose Tolerance
70%
Hyperglycemia
59%
Fibrinogen
53%
Cardiotrophin 1
53%
Blood Plasma
52%
Insulin Resistance
52%
Body Mass
38%
Farnesoid X Receptor
35%
Hedgehog
35%
Blood Lipid
35%
Growth Differentiation Factor
35%
Glucose Transport
25%
C-Reactive Protein
21%
Glucose Blood Level
21%
Blood Level
21%
Glucose Level
19%
Sleep Time
17%
Lung Function
17%
Overall Survival
17%
Adhesion Protein
17%
Catalase-Peroxidase
17%
Fetuin
17%
Insulin-Like Growth Factor 1
17%
Immune Checkpoints
17%
Progression Free Survival
17%
Phosphoenolpyruvate Carboxykinase
17%
Ghrelin
17%
Agmatine
17%
Oxidation Reduction Potential
17%
Oncogenic activity
17%
Protein Expression
17%
Opioid Receptor
17%
Fetus Growth
17%
Acetaldehyde Dehydrogenase
17%
Enkephalinase
17%
Angiopoietin
17%
Eicosapentaenoic Acid
17%
Hepatocyte
17%
Glutathione Peroxidase
17%
calcium activated,phospholipid dependent protein kinase
17%
Aldehyde Dehydrogenase
17%
Retinol Binding Protein 4
17%
Lipid Level
17%
Upregulation
17%
Skeletal Muscle
17%
C2C12
17%
Prospective Cohort Study
17%
Free Fatty Acid Receptor 1
17%
Solution and Solubility
17%
Keyphrases
Hepassocin
53%
Insulin Resistance
38%
Hedgehog Proteins
35%
Pre-diabetes (pre-DM)
35%
HepG2 Cells
27%
Hepatic Steatosis
26%
β-endorphin
26%
Oleic Acid
25%
Streptozotocin-induced Diabetic Rats
25%
Plasma Glucose
22%
GPR40
22%
Impaired Fasting Glucose
20%
Hepatokine
20%
Adrenal Gland
20%
Protein Level
20%
New-onset Diabetes
20%
Type 2 Diabetes Mellitus (T2DM)
19%
New-onset Type 2 Diabetes
17%
AceK
17%
Secretogranin III
17%
Stevioside
17%
Propanediol
17%
Brain Astrocytes
17%
Sweet Taste Receptor
17%
CT-1
17%
Agmatine
17%
Fomitopsis pinicola
17%
Autonomic Regulation
17%
Ginseng
17%
Fungal Extracts
17%
Pubertal Growth
17%
Obese Sarcopenia
17%
Fetuin-A
17%
Serotonin Uptake
17%
In Vitro Granuloma Model
17%
Prothymosin alpha (ProTα)
17%
Astrocytic Processes
17%
Signal Transducer and Activator of Transcription 3
17%
Arborization
17%
Cancer Progression
17%
Anti-hepatocellular Carcinoma Activity
17%
Unsaturated Fatty Acids
17%
Steatotic
17%
Hepatic Dysfunction
17%
Murine Liver
17%
ELOVL6
17%
Rilmenidine
17%
Type 2 Response
17%
Typographical Error
17%
Infiltrative Hepatocellular Carcinoma
17%
